Can Belzutifan Improve Adjuvant Therapy?

• by Kathryn Wighton

• July 8, 2026

Newborn variants may flag childhood cancer predisposition

Targeted sequencing identified cancer-risk variants in about 7% of pediatric patients who later developed early-onset solid or brain malignancies.

• by Andrea Surnit

• August 28, 2026

• 4 min

Does portal writing style contribute to disparities in clinician response?

Message length, punctuation, and clinician greetings were associated with intended clinician response.

• by Andrea Surnit

• August 27, 2026

• 4 min

FDA revises monitoring for SCLC therapy

Initial monitoring decreases from 22 to 24 hours to 6 to 8 hours from the start of the first 2 infusions.

• by Kathryn Wighton

• September 15, 2026

• 2 min